Biotech firm KaloBios Pharmaceuticals Inc., under scrutiny following the arrest of its former Chief Executive Martin Shkreli, said Tuesday that an appeal of its delisting from the Nasdaq Stock Market has been scheduled for Feb. 25, 2016.
from WSJ.com: US Business http://ift.tt/1NUm05H
via IFTTT
No comments:
Post a Comment